Pfizer gets EU nod for ulcerative colitis drug Velsipity
Pfizer’s drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission, the company said on Monday. The approval for Velsipity follows backing from the European Medicines Agency’s panel of experts in December. The drug was approved for use in patients aged 16 or older and who […]